Cargando…
Rituximab and Canakinumab Use During Lactation: No Detectable Serum Levels in Breastfed Infants
INTRODUCTION: In breastfeeding patients with chronic inflammatory rheumatic diseases, a postpartum flare may require the use of biologics. However, data on the safety of biologics during lactation are scarce, potentially impeding the decision-making process. CASE SERIES: We report two cases of women...
Autores principales: | Bosshard, Nicole, Zbinden, Astrid, Eriksson, Klara Kristin, Förger, Frauke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8217349/ https://www.ncbi.nlm.nih.gov/pubmed/33999372 http://dx.doi.org/10.1007/s40744-021-00313-z |
Ejemplares similares
-
Primaquine Pharmacokinetics in Lactating Women and Breastfed Infant Exposures
por: Gilder, Mary Ellen, et al.
Publicado: (2018) -
Iron and the Breastfed Infant
por: Friel, James, et al.
Publicado: (2018) -
Growth performance comparison of exclusively breastfed infants with partially breastfed and formula fed infants
por: Zong, Xin-Nan, et al.
Publicado: (2020) -
Development of Visceral and Subcutaneous-Abdominal Adipose Tissue in Breastfed Infants during First Year of Lactation
por: Gridneva, Zoya, et al.
Publicado: (2021) -
Bisphenol A Exposure in Exclusively Breastfed Infants and Lactating Women: An Observational Cross-sectional Study
por: Çiftçi, Seda, et al.
Publicado: (2021)